Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology

Journal Article · · Chemical Research in Toxicology
 [1];  [1];  [2];  [1];  [2];  [1]
  1. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
  2. UC Davis Medical Center, Sacramento, CA (United States); Accelerated Medical Diagnostics Inc., Berkeley, CA (United States)

Accelerator mass spectrometry (AMS) has been adopted as a powerful bioanalytical method for human studies in the areas of pharmacology and toxicology. The exquisite sensitivity (10–18 mol) of AMS has facilitated studies of toxins and drugs at environmentally and physiologically relevant concentrations in humans. Such studies include risk assessment of environmental toxicants, drug candidate selection, absolute bioavailability determination, and more recently, assessment of drug-target binding as a biomarker of response to chemotherapy. Combining AMS with complementary capabilities such as high performance liquid chromatography (HPLC) can maximize data within a single experiment and provide additional insight when assessing drugs and toxins, such as metabolic profiling. Recent advances in the AMS technology at Lawrence Livermore National Laboratory have allowed for direct coupling of AMS with complementary capabilities such as HPLC via a liquid sample moving wire interface, offering greater sensitivity compared to that of graphite-based analysis, therefore enabling the use of lower 14C and chemical doses, which are imperative for clinical testing. In conclusion, the aim of this review is to highlight the recent efforts in human studies using AMS, including technological advancements and discussion of the continued promise of AMS for innovative clinical based research.

Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH)
Grant/Contract Number:
AC52-07NA27344
OSTI ID:
1367988
Report Number(s):
LLNL-JRNL--696717
Journal Information:
Chemical Research in Toxicology, Journal Name: Chemical Research in Toxicology Journal Issue: 12 Vol. 29; ISSN 0893-228X
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (82)

Comparison of DNA‐adduct and tissue‐available dose levels of MeIQx in human and rodent colon following administration of a very low dose journal February 1999
DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy journal March 2000
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay journal June 1994
Pediatric microdose and microtracer studies using 14 C in Europe journal July 2015
Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT) journal January 2006
A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance journal March 2011
Applications of accelerator mass spectrometry for pharmacological and toxicological research journal January 2005
Intrinsic Erythrocyte Labeling and Attomole Pharmacokinetic Tracing of14C-Labeled Folic Acid with Accelerator Mass Spectrometry journal May 1999
Chlorophyllin Chemoprevention in Trout Initiated by Aflatoxin B1 Bath Treatment: An Evaluation of Reduced Bioavailability vs. Target Organ Protective Mechanisms journal July 1999
The Dynamics of Folic Acid Metabolism in an Adult Given a Small Tracer Dose of 14C-Folic Acid book January 1998
A microdose study of 14C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung journal June 2013
Human mass balance study of TAS-102 using 14C analyzed by accelerator mass spectrometry journal January 2016
Platinum-based drugs: past, present and future journal February 2016
Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials journal November 2011
Pediatric Microdose Study of [14C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept journal September 2014
Accelerator mass spectrometry in the biomedical sciences: applications in low-exposure biomedical and environmental dosimetry journal December 1990
Long-term kinetic study of β-carotene, using accelerator mass spectrometry in an adult volunteer journal November 2000
Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin journal March 2003
On-line combustion of samples for AMS and ion source developments at ORAU journal October 2000
Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses journal September 1999
Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing journal May 2003
In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography journal March 2001
Impact of microdosing clinical study — Why necessary and how useful? journal June 2011
Approaches using molecular imaging technology — use of PET in clinical microdose studies journal June 2011
Retrospective Birth Dating of Cells in Humans journal July 2005
Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs journal September 2006
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies journal October 2015
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies journal June 2016
Cisplatin in cancer therapy: Molecular mechanisms of action journal October 2014
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers journal June 2011
AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects journal November 2013
A gas ion source for radiocarbon measurement at SUERC
  • Xu, Sheng; Dougans, Andrew; Freeman, Stewart P. H. T.
  • Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, Vol. 259, Issue 1 https://doi.org/10.1016/j.nimb.2007.01.311
journal June 2007
Direct measurements of small 14C samples after oxidation in quartz tubes
  • Fahrni, S. M.; Gäggeler, H. W.; Hajdas, I.
  • Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, Vol. 268, Issue 7-8 https://doi.org/10.1016/j.nimb.2009.10.031
journal April 2010
An interface for the direct coupling of small liquid samples to AMS journal October 2015
Direct Coupling of an Elemental Analyzer and a Hybrid Ion Source for AMS Measurements journal January 2004
A Gas Ion Source for Radiocarbon Measurements at 200 kV journal January 2007
Rapid Production of Graphite Without Contamination for Biomedical AMS journal January 1992
A High-Throughput Method for the Conversion of CO 2 Obtained from Biochemical Samples to Graphite in Septa-Sealed Vials for Quantification of 14 C via Accelerator Mass Spectrometry journal May 2003
Ultrahigh Efficiency Moving Wire Combustion Interface for Online Coupling of High-Performance Liquid Chromatography (HPLC) journal December 2011
Directly Coupled High-Performance Liquid Chromatography–Accelerator Mass Spectrometry Measurement of Chemically Modified Protein and Peptides journal March 2013
Automated Combustion Accelerator Mass Spectrometry for the Analysis of Biomedical Samples in the Low Attomole Range journal July 2014
HPLC−Accelerator MS Measurement of Atrazine Metabolites in Human Urine after Dermal Exposure journal August 1999
Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5- f ]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans journal March 2016
Determining the Pharmacokinetics and Long-Term Biodistribution of SiO 2 Nanoparticles In Vivo Using Accelerator Mass Spectrometry journal October 2012
Kinetics of Carboplatin−DNA Binding in Genomic DNA and Bladder Cancer Cells As Determined by Accelerator Mass Spectrometry journal May 2006
Gemcitabine Causes Minimal Modulation of Carboplatin-DNA Monoadduct Formation and Repair in Bladder Cancer Cells journal November 2010
Human in Vivo Pharmacokinetics of [ 14 C]Dibenzo[ def,p ]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing journal December 2014
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours journal June 1996
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy journal December 1997
Systems biology of cisplatin resistance: past, present and future journal May 2014
The resurgence of platinum-based cancer chemotherapy journal July 2007
Big physics, small doses: the use of AMS and PET in human microdosing of development drugs journal March 2003
Cellular processing of platinum anticancer drugs journal March 2005
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients journal May 2008
Human vitamin B12 absorption measurement by accelerator mass spectrometry using specifically labeled 14C-cobalamin journal April 2006
Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)–DNA adducts in human pancreatic tissues journal January 2006
Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry journal January 1991
Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo[4,5- f ]qiiinoline (IQ) to rat liver DNA journal January 1992
The measurement of cisplatin-DNA adduct levels in testicular cancer patients journal January 1988
Use of Positron Emission Tomography in Animal Research journal January 2001
Well-Done Meat Intake and the Risk of Breast Cancer journal November 1998
Observational infant exploratory [ 14 C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis : Paediatric paracetamol microdose/therapeutic exploratory PK study journal June 2015
Evaluation of Microdosing Strategies for Studies in Preclinical drug Development: Demonstration of Linear Pharmacokinetics in dogs of a Nucleoside Analog over a 50-Fold dose Range journal July 2004
A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry journal May 2011
Disposition and Metabolic Profiling of [ 14 C]Cerlapirdine Using Accelerator Mass Spectrometry journal September 2014
Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice journal July 2015
Use of Microdosing and Accelerator Mass Spectrometry To Evaluate the Pharmacokinetic Linearity of a Novel Tricyclic GyrB/ParE Inhibitor in Rats journal August 2014
The Urinary Metabolite Profile of the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5- b ]Pyridine Is Predictive of Colon DNA Adducts after a Low-Dose Exposure in Humans journal November 2006
Pharmacokinetic Investigation of Imatinib Using Accelerator Mass Spectrometry in Patients with Chronic Myeloid Leukemia journal July 2007
Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B 1 Pharmacokinetics in Human Volunteers journal December 2009
Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer journal September 2012
Significant Human β-Cell Turnover Is Limited to the First Three Decades of Life as Determined by in Vivo Thymidine Analog Incorporation and Radiocarbon Dating journal October 2010
Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer journal January 2016
The use of isotopes in the determination of absolute bioavailability of drugs in humans journal May 2006
Effective Use of Microdosing and Positron Emission Tomography (PET) Studies on New Drug Discovery and Development journal January 2009
A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil journal January 2011
Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical Research journal July 2000
Human microdosing for the prediction of patient response journal March 2010
Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data journal March 2010
The debate is over: accelerator MS provides the route to better drug-development paradigms/protocols journal February 2011
Applications of accelerator MS in pediatric drug evaluation journal August 2012
Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer journal February 2013

Cited By (2)

Nanotracing and cavity-ring down spectroscopy: A new ultrasensitive approach in large molecule drug disposition studies journal October 2018
Synthesis of carbon-14-labelled peptides journal August 2019

Similar Records

Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science
Journal Article · Thu May 09 00:00:00 EDT 2019 · Toxics · OSTI ID:1529655

In silico toxicology for the pharmaceutical sciences
Journal Article · Mon Dec 14 23:00:00 EST 2009 · Toxicology and Applied Pharmacology · OSTI ID:21344819

Related Subjects